Drug
Comparator Sitagliptin
Comparator Sitagliptin: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Comparator: sitagliptin 100 mg NCT00094757 | Phase 3 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Comparator Sitagliptin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.